Pratik S. Multani - 15 Dec 2022 Form 4/A - Amendment Insider Report for Oric Pharmaceuticals, Inc. (ORIC)

Role
Chief Medical Officer
Signature
/s/ Christian Kuhlen, attorney-in-fact
Issuer symbol
ORIC
Transactions as of
15 Dec 2022
Net transactions value
-$6,846
Form type
4/A - Amendment
Filing time
17 Feb 2023, 15:25:07 UTC
Date Of Original Report
16 Dec 2022
Previous filing
21 Jul 2022
Next filing
02 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ORIC Common Stock Sale $6,846 -2,227 -23% $3.07 7,285 15 Dec 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This amendment is filed to correct the number of shares sold, and the price per share at which the shares were sold, to cover the tax withholding obligations in connection with the vesting of RSUs reported in the Form 4 filed December 16, 2022 and does not represent a discretionary sale by the Reporting Person.